Navinta Llc, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Apothecon- Your trusted partner for APIs & HPAPIs// Emerging leader in therapeutic generic drugs.
One of their notable products is MARAVIROC, with a corresponding US DMF Number 36917.
Remarkably, this DMF maintains an Active status since its submission on March 30, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 27, 2022, and payment made on August 10, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II